Adjuvant Therapy of Pancreatic Cancer
- Author:
Woo Hyun PAIK
1
Author Information
1. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. whpaik@snuh.org
- Publication Type:Review
- Keywords:
Pancreatic cancer;
Adjuvant therapy;
FOLFIRINOX;
Recurrence
- MeSH:
Diagnosis;
Drug Therapy;
Humans;
Korea;
Pancreatic Neoplasms;
Recurrence
- From:
Journal of Digestive Cancer Report
2019;7(1):5-7
- CountryRepublic of Korea
- Language:English
-
Abstract:
Pancreatic cancer is a lethal disease since curative resection is available in only 20% of patients at the initial diagnosis. Even after radical resection of the cancer, most patients experience recurrence. Therefore, many clinical trials have been attempted to prevent recurrence of pancreatic cancer. The key clinical studies about adjuvant therapy of pancreatic cancer and currently available regimens in Korea will be reviewed concisely according to the chemotherapy, radiation therapy, or both.
